NCT07210047 2025-10-07
Study of HuL001 in Relapsed/Refractory Multiple Myeloma Patients
HuniLife Biotechnology, Inc.
Phase 1/2 Enrolling by invitation
HuniLife Biotechnology, Inc.
Vitebsk Regional Clinical Cancer Centre
Second Affiliated Hospital of Soochow University